News & Updates

Show Multimedia Only
Immune-related adverse events portend better prognosis in ICI-treated hepatocellular carcinoma

Immune-related adverse events portend better prognosis in ICI-treated hepatocellular carcinoma

08 Mar 2022 byJairia Dela Cruz

Among advanced hepatocellular carcinoma patients being treated with immune checkpoint inhibitors (ICIs), the occurrence of multisystem and more severe immune-related adverse events is a favourable signal, being associated with survival advantage, according to a Singapore study.

08 Mar 2022
Medication risks an acceptable trade-off for cure of IBS symptoms

Medication risks an acceptable trade-off for cure of IBS symptoms

07 Mar 2022

Patients with irritable bowel syndrome (IBS) are willing to take on significant medication risks in exchange for a permanent cure of their symptoms, a study has found.

07 Mar 2022